Butabarbital decreases results of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers might lower sufentanil levels and efficacy, perhaps precipitating withdrawal syndrome in people that have created Bodily dependence to sufentanil. Discontinuation of concomitantly utilized CYP3A4 inducers may pe... https://wesleyd654sbi4.blognody.com/profile